A VIRTUAL CELEBRATION: 10 YEARS OF GREAT LADIES
|
|
|
The Alzheimer’s Drug Discovery Foundation (ADDF) re-imagined our annual Great Ladies Luncheon & Fashion Show as a virtual experience, as friends from around the nation gathered to celebrate a decade of science and fashion on May 6. Hosted by broadcast legend Andrea Mitchell, the event featured a discussion about new advancements in Alzheimer’s research between Dr. Howard Fillit and Dr. Roberta Diaz Brinton. The program also included an appearance from Washington Capitals player and 2019 Great Ladies honoree, T.J. Oshie, who thanked the ADDF for its dedication to finding a cure for Alzheimer’s. A special tribute to event founder Elise Lefkowitz by her daughter Charlie Lefkowitz Crowley accompanied a look-back at fashion highlights from years past. To view the virtual event, click here.
|
|
|
Diagnostics Accelerator
The ADDF announced several new research awards through its Diagnostics Accelerator (DxA) initiative including its first digital biomarker research award with Cogstate Ltd. as well as a partnership with Sage Bionetworks. Learn more.
|
|
|
Grants Announcement
The ADDF announced six new investments, including three in partnership with the Association for Frontotemporal Degeneration (AFTD), which focused on frontotemporal dementia (FTD), a rare type of dementia that most often strikes adults in their 40s and 50s. Read more.
|
|
|
Notable Trials and Studies
Alzheimer’s research continues to be in the news, even in the face of the COVID-19 pandemic. We took a look at some recent developments: the A4 trial (Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease), the ASPREE trial (Aspirin in Reducing Events in the Elderly), and the DIAN-TU study.
|
|
|
Bridging the Gap from Early Drug Discovery to Clinical Development
Dr. Eugenia Trushina of Mayo Clinic Rochester, the 2019 ADDF-Harrington Scholar, discusses the impact the award has had on her research with its unique structure, providing in-depth advisory support from pharmaceutical industry experts on the Harrington team in addition to funding. Find out more.
|
|
|
Can flavonols prevent Alzheimer’s disease?
A recent study reported that people who had high dietary intakes of flavonols had reduced risks of developing Alzheimer’s disease. Read more.
|
|
|
Is there a link between the immune system and cognitive health?
The aging-related decline in immune system function may increase the risk for cognitive decline, especially in men. But diet and exercise can help delay the decline in immunity. Read more.
|
|
ADDF IN THE NEWS
- The ADDF’s blog, Alzheimer’s Matters, was recently recognized by Healthline as one of the best Alzheimer’s blogs of 2020. The articles heralds Alzheimer’s Matters as “a useful place for anyone actively seeking advances and developments in the fight against this disease.”
- In a series of video interviews with Neurology Live, Dr. Howard discusses how geriatricians are adapting to telemedicine and the impacts of COVID-19 on Alzheimer’s caregivers.
- In an article from Medscape, Dr. Fillit comments on a new study about repercussions of the 2005 FDA black-box warning on atypical antipsychotic (AAP) use in elderly patients with dementia.
- In a story for Healthline, Dr. Fillit shares information on managing your risk for Alzheimer’s.
- The Palm Beach Daily News profiles the ADDF’s Palm Beach Luncheon and the contributions of our organization to Alzheimer’s research.
|
|
|
|
|
|
